Showing results (481-490 of 928) with videos related to

Sort By:
Pageof 93
Journal of Psychiatric Research|June 11, 2020
Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled studyMakoto Kamiya, Helene D Sabia, Julie Marella, et al.
British Journal of Clinical Pharmacology|May 19, 2022
The role of placebo response in the efficacy outcome assessment in viloxazine extended-release pivotal trials in paediatric subjects with attention-deficit/hyperactivity disorderAzmi Nasser, Roberto Gomeni, Zhao Wang, et al.
Psychiatry Research|October 2, 2018
Anxiety attacks with or without life-threatening situations, major depressive disorder, and suicide attempt: a nationwide community sample of Korean adultsHyewon Kim, Kwan Woo Choi, Eun Jin Na, et al.
Depression and Anxiety|December 8, 2011
What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?Jackie K Gollan, Maurizio Fava, Benji Kurian, et al.
The Journal of Clinical Psychiatry|March 9, 2004
Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorderGeorge I Papakostas, Timothy J Petersen, Andrew A Nierenberg, et al.
Psychiatry (Edgmont (Pa. : Township))|September 1, 2010
Using daily interactive voice response assessments: to measure onset of symptom improvement with duloxetineHeidi K Moore, Madelaine M Wohlreich, Michael G Wilson, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|February 26, 2013
Association between smoking and heart rate variability among individuals with depressionChristopher B Harte, Gabrielle I Liverant, Denise M Sloan, et al.
The Journal of Pain|October 4, 2019
WITHDRAWN: Size Does Matter, But It Isn't Everything: The Challenge of Modest Treatment Effects in Chronic Pain Clinical TrialsShannon M Smith, Maurizio Fava, Mark P Jensen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 22, 2008
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D studyRoy H Perlis, Priya Moorjani, Jesen Fagerness, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 15, 2003
The pharmacologic management of SSRI-induced side effects: a survey of psychiatristsChristina M Dording, David Mischoulon, Timothy J Petersen, et al.
Pageof 93